Cargando…
How to Avoid Coronary Occlusion During TAVR Valve-in-Valve Procedures
Transcatheter aortic valve-in-valve replacement has been recently reported as a less-invasive alternative to re-do surgery in patients with bioprosthetic valve failure. Although procedural success is achieved in the great majority of patients, this therapy is associated with several potential compli...
Autores principales: | Valvo, Roberto, Costa, Giuliano, Barbanti, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6877473/ https://www.ncbi.nlm.nih.gov/pubmed/31803761 http://dx.doi.org/10.3389/fcvm.2019.00168 |
Ejemplares similares
-
Antithrombotic Therapy in Transcatheter Aortic Valve Replacement
por: Valvo, Roberto, et al.
Publicado: (2019) -
New adverse coronary events in valve-in-valve TAVR and native TAVR—A 2-year matched cohort
por: Koren, Ofir, et al.
Publicado: (2022) -
Valve-in-Valve Challenges: How to Avoid Coronary Obstruction
por: Bernardi, Fernando L. M., et al.
Publicado: (2019) -
Frequency of Bioprosthetic Valve Fracturing Utilization in an All-Comers Valve-in-Valve TAVR Cohort
por: Ruge, Hendrik, et al.
Publicado: (2021) -
Emergently Alteration of Procedural Strategy During Transcatheter Aortic Valve Replacement to Prevent Coronary Occlusion: A Case Report
por: Dai, Hanyi, et al.
Publicado: (2022)